Diamyd Logo
This website is only intended for investors

Fighting diabetes

Diamyd Medical is a diabetes company active in the field of pharmaceutical development. The Company is headquartered in Stockholm, Sweden and shares are listed on NASDAQ OMX First North (ticker: DMYD B).
The new Diamyd will be a dedicated diabetes company with an initial focus on the development of the diabetes vaccine Diamyd®
Diabetes is associated with serious complications due to elevated and fluctuating blood sugar levels, causing substantial suffering and extensive costs for society.
The listing of the new Diamyd Medical AB on First North marks the start of a new, exciting chapter for our diabetes operation. The new Diamyd is a dedicated diabetes company with an initial focus on the diabetes...
Diamyd® is a GAD-based therapy under development for the treatment and prevention of autoimmune diabetes such as type 1 diabetes and LADA. Treatment with Diamyd® aims to intervene in the autoimmune...
    
No reports available.